IHS Chemical Week

People & Business :: Companies

Lonza Withdraws Bid to Acquire Patheon

12:05 AM MDT | October 20, 2009 | Deepti Ramesh

Lonza says it has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of pharmaceutical contract manufacturing and development services company Patheon (Toronto), due to “a combination of factors including value considerations, and the rejection of the Lonza proposal by the majority shareholder of Patheon.”  The proposal was rejected by private equity firm JLL Partners (New York), which owns 57% of Patheon, say press reports. Lonza submitted a non-binding proposal, in August, to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa